Showing 1111-1120 of 20387 results for "".
Practical Dermatology Roundtable: The Role of Adjuvant Skin Cleansing and Moisturizing in Treating Psoriasis and Other Inflammatory Diseases, Ch. 2
https://reachmd.com/programs/the-practical-dermatology-roundtable/practical-dermatology-roundtable-the-role-of-adjuvant-skin-cleansing-and-moisturizing-in-treating-psoriasis-and-other-inflammatory-diseases-ch-2/56870/In the second installment of a nine-part series, host Ted Lain, MD, MBA, FAAD, and guests Zoe Diana Draelos, MD, and Firas George Hougeir, MD, FAAD, review the study design, including patient selection, treatment regimens, and objective and subjective assessment methods used to evaluate outcomes.1Case Application: Frontline Insights—Tackling Newly Diagnosed Myeloma
https://reachmd.com/programs/cme/case-application-frontline-insightstackling-newly-diagnosed-myeloma/36573/Beyond the Horizon in Multiple Myeloma: Harnessing Novel CELMoD Mechanisms for Increased Antimyeloma ActivityEarly Initiation of Acoramidis in ATTR-CM: Importance and Long-Term Impacts
https://reachmd.com/programs/heart-matters/early-initiation-of-acoramidis-in-attr-cm-importance-and-long-term-impacts/35757/Acoramidis, a treatment for transthyretin amyloid cardiomyopathy (ATTR-CM), was studied in an open-label extension of the ATTRibute-CM trial to determine whether its early and sustained use improves clinical outcomes. Discover acoramidis’ long-term impacts on all-cause mortality and/or first cardiovTreating R/R Classic Hodgkin Lymphoma: Ipilimumab and Other Approaches
https://reachmd.com/programs/project-oncology/treating-rr-classic-hodgkin-lymphoma-ipilimumab-and-other-approaches/26405/Read about the efficacy and safety of ipilimumab as a standalone treatment for relapsed or refractory classic Hodgkin lymphoma.Employing Immunotherapy and ADCs in Advanced Endometrial and Cervical Cancers: Current and Emerging Therapies
https://reachmd.com/programs/cme/employing-immunotherapy-and-adcs-in-advanced-endometrial-and-cervical-cancers-current-and-emerging-therapies/14460/Our experts are breaking down evolving treatments for advanced endometrial & cervical cancer. Hear the latest data on immunotherapy and ADCs now!Investigating the Circulation of Counterfeit COVID-19 Medications
https://reachmd.com/programs/covid-19-frontlines/investigating-the-circulation-of-counterfeit-covid-19-medications/11624/The worldwide shortfall of drugs and drug supplies has fueled an illicit trade market for illegal pharmaceuticals and medical items.Renin-Angiotensin-Aldosterone System Inhibitors in Patients with COVID-19
https://reachmd.com/programs/the-drug-report/renin-angiotensin-aldosterone-system-inhibitors-in-patients-with-covid-19/11416/Do the benefits of continuing the use of RAAS inhibitors in patients outweigh the risks due to the inhibitors’ potential link to COVID-19 severity?Improving Quality Care Across the Spectrum of HER2 Expression in HR+ Metastatic Breast Cancers: Practice Changes to Improve Care
https://reachmd.com/programs/cme/improving-quality-care-across-the-spectrum-of-her2-expression-in-hr-metastatic-breast-cancers-practice-changes-to-improve-care/32203/This panel discussion reviews successes, challenges, and practice insights from a Quality Improvement (QI) initiative in metastatic breast cancer.Test Your Skills and Learn From Experts on IL-13 Inhibitors in Moderate to Severe Atopic Dermatitis
https://reachmd.com/programs/cme/test-your-skills-and-learn-from-experts-on-il-13-inhibitors-in-moderate-to-severe-atopic-dermatitis/37624/Watch an expert-led case discussion on the role of IL-13 in moderate to severe atopic dermatitis and the efficacy on its inhibition through biologic therapies to achieve control.Modern Obstructive HCM Care: From Unmet Needs to Individualized Myosin Inhibitor Therapy
https://reachmd.com/programs/cme/modern-obstructive-hcm-care-from-unmet-needs-to-individualized-myosin-inhibitor-therapy/54306/Explore how cardiac myosin inhibitors are reshaping obstructive HCM management, from unmet needs to individualized, evidence-based treatment.